Virtual ENCALS meeting 2021

This year, ENCALS (European Network to Cure ALS) will be organising their…

Words Lucie van Leeuwen.Published March 12, 2021
Virtual ENCALS meeting 2021

This year, ENCALS (European Network to Cure ALS) will be organising their annual meeting online. The meeting will take place on 12-14 May. Registration and abstract submission are now open.

More details of the programme will be announced once abstract submission has closed. Keep an eye on the ENCALS website to stay updated.

Registration and abstract submission

It is now possible to register for the Virtual ENCALS Meeting 2021 by accessing the following link: https://kuonicongress.eventsair.com/encals21/reg/Site/Register. For more information about registration fees, please visit the ENCALS website.

Abstracts can be submitted until 11:59 PM CET on Friday March 26th via: https://kuonicongress.eventsair.com/encals21/abstract-portal. Please note that you need to register for the event before you can submit an abstract. All abstracts will be reviewed by the ENCALS Programme Committee 2021. Applicants will receive a notification of acceptance as platform or poster presentation as soon as possible.

Sponsorship

Are you interested in sponsoring the Virtual ENCALS Meeting 2021? Please ask for the Sponsorship Prospectus 2021 via info@encals.eu.

 


Share

Related news

The Lalji Family ALS Award
The Lalji Family ALS Award
The Lalji Family ALS Award is a global prize celebrating excellence in […]
More patients eligible for treatment research through innovative study design
More patients eligible for treatment research through innovative study design
Due to a new trial design for treatment research, more ALS patients […]
Amylyx Pharmaceuticals and TRICALS to collaborate on phase 3 clinical trial
Amylyx Pharmaceuticals and TRICALS to collaborate on phase 3 clinical trial
Today, Amylyx Pharmaceuticals provided an update on its plans to advance its […]
Retrotope announces initiation of RT001 study in people with ALS
Retrotope announces initiation of RT001 study in people with ALS
Retrotope Inc has announced that the first participants have been enrolled in […]